News | News By Subject | News by Disease News By Date | Search News

Parkinson's disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Acorda (ACOR) Rockets After Parkinson's Drug Hits Late-Stage Goals     2/10/2017
Merck KGaA (MKGAF.PK) Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's Trials     2/7/2017
Key Parkinson's Trial Delayed Due to Feud Between a Georgetown University Scientist and The Michael J. Fox Foundation     8/31/2016
Acadia (ACAD) Drug Approval May Make It an Attractive Target for Biogen (BIIB), Teva (TEVA)     5/9/2016
FDA Clears Acadia (ACAD)'s NUPLAZID, the First Drug for Psychosis Linked to Parkinson's     5/2/2016
Acorda (ACOR)'s Parkinson’s Candidate Meets Goal in Phase II Trial     4/20/2016
Acadia (ACAD) Surges as FDA Panel Backs Psychosis Drug Linked to Parkinson’s Disease     3/30/2016
FDA Staff Says Acadia (ACAD)'s Drug for Parkinson's Disease Psychosis Nuplazid is Effective     3/28/2016
Three Biotechs Cited as Promising Bets in 2016 With FDA Decisions Pending     2/22/2016
Acorda (ACOR) Bulks Up Parkinson's Pipeline with $363 Million Takeover of Biotie     1/20/2016
Adamas Pharmaceuticals (ADMS)' Lead Drug ADS-5102 Meets Phase III Goals; Stock Surges     12/28/2015
Novartis AG (NVS) Cancer Drug May Help Parkinson's Patients     10/19/2015
Exciting Time for Biotech in New Jersey     6/29/2015
Pfizer (PFE) Agrees to Pay Off Parkinson Patients Who Developed Gambling and Sex Addiction While On Cabaser     5/11/2015
FDA Lifts Clinical Hold on NeuroDerm (NDRM)'s Lead Parkinson's Candidates     5/11/2015

News from Around the Web
A Watch Fights Tremors And Woman Finds Ability To Write, Microsoft Reveals     5/15/2017
To Probe Parkinson’s, Treat The Brain Like A Piece Of Electronics, Stanford University Study     1/30/2017
Parkinson's Linked To Gut Bacteria, California Institute of Technology Study     12/2/2016
How This Small Wearable Could Help Doctors Spot Parkinson's Earlier, University Politehnica Of Bucharest Study     9/16/2016
DNA Brain Injection Could Help Control Parkinson's Symptoms, Voyager Therapeutics (VYGR) Reveals     8/23/2016
Eye Test May Detect Parkinson’s Before Symptoms Appear, University College London Study     8/19/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
Cancer Drug Could Help Parkinson's, Dementia Patients, Georgetown University Study     7/14/2016
Detecting Parkinson’s Through A Urine Test, University of Alabama at Birmingham Study     7/8/2016
Blocking Key Enzyme Halts Parkinson's Disease Symptoms In Mice, Johns Hopkins University Study     6/29/2016
Pesticide-Linked Parkinson's Disease May Be Preventable, UCLA Scientists Reveal     6/16/2016
New Approaches To Early Identification Of Parkinson’s Disease     5/31/2016
Electronic Device Detects Molecules Linked To Cancer, Alzheimer's And Parkinson's, National Nanotechnology Laboratory Study     5/20/2016
Granddaughter Of Parkinson's Patient Invents "Smart" Walking Stick To Help Thousands Of Suffers, University of the West of England Study     5/18/2016
This Tremor Tracking Wearable Lets Parkinson's And ET Patients Take Charge     5/17/2016

Press Releases
NeuroDerm (NDRM) ND0612H Phase II Trial Results To Be Presented In Late-Breaking Session At The 21st International Congress Of Parkinson’s Disease And Movement Disorders     5/23/2017
Enterin's RASMET Study Enrolls First Patient With Parkinson's Disease     5/16/2017
International Stem Cell Corporation Receives Approval To Start Second Patient Cohort In Clinical Trial For Parkinson’s Disease     5/9/2017
Living Cell Tech Release: Treatment Completed For All Patients In Parkinson’s Trial     5/1/2017
Britannia Pharmaceuticals Limited: Landmark Apomorphine Study Confirms Its Established Role As A Highly Effective Treatment For Parkinson's Disease Patients Whose Symptoms Cannot Be Controlled On Standard Therapies     4/26/2017
Voyager Therapeutics (VYGR) Announces Additional Results From Phase Ib Trial Of VY-AADC01 For Advanced Parkinson’s Disease     4/25/2017
International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial     4/25/2017
Adamas Pharma (ADMS) Presents ADS-5102 Pooled Phase III Data Confirming Statistically Significant Reduction In Levodopa-Induced Dyskinesia And OFF Time In People With Parkinson’s Disease     4/24/2017
Klick Labs Debuts First Device To Record And Transmit Parkinson’s Tremors; Highlights Link Between Clinical Empathy And Improved Patient Outcomes     4/24/2017
Medtronic (MDT) Brain Therapies Business Sponsors Parkinson's Unity Walk     4/20/2017
Valeo Pharma And Zambon Form Partnership For Parkinson's Disease Treatment Xadago (Safinamide) In Canada     4/11/2017
MANUS Neurodynamica Release: SBRI Healthcare Development Contract For Parkinson’s Diagnostic Pen For GPs     4/11/2017
Bracket To Develop Electronic Versions Of MDS-UPDRS And Udysrs For Parkinson's Disease Trial Assessments     4/4/2017
Clinical Results Presented From Prothena (PRTA)’s Phase Ib Study Of PRX002/RG7935 Demonstrating Robust Antibody CNS Penetration And Significant Reduction Of Free Serum Alpha-Synuclein In Patients With Parkinson’s Disease     4/3/2017
Intec Pharma Provides Update On Phase III ACCORDANCE Study Of The Accordion Pill Carbidopa/Levodopa In Parkinson's Disease Patients     3/29/2017

//-->